HAP Trading’s Edwards Lifesciences EW Stock Holding History

HAP Trading’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$332K	Buy	+78,000	New	+$6.09M	0.02%	319
2024 Q4	–	Sell	-253,100	Closed	-$32.3K	–	771
2024 Q3	$32.3K	Buy	+253,100	New	+$18.4M	﹤0.01%	515
2022 Q3	–	Sell	-14,600	Closed	-$27K	–	1817
2022 Q2	$27K	Buy	+14,600	New	+$1.51M	﹤0.01%	1250
2022 Q1	–	Sell	-25,900	Closed	-$257K	–	2394
2021 Q4	$257K	Buy	+25,900	New	+$3.02M	0.01%	929
2021 Q3	–	Sell	-10,000	Closed	-$70K	–	2514
2021 Q2	$70K	Buy	+10,000	New	+$943K	﹤0.01%	1347
2020 Q2	–	Sell	-33,900	Closed	-$21K	–	1751
2020 Q1	$21K	Buy	+33,900	New	+$2.44M	﹤0.01%	919
2019 Q2	–	Sell	-218,700	Closed	-$157K	–	1186
2019 Q1	$157K	Buy	+218,700	New	+$12.5M	0.01%	481
2016 Q2	–	Sell	-291,300	Closed	-$262K	–	945
2016 Q1	$262K	Buy	+291,300	New	+$8.04M	0.02%	368
2013 Q4	–	Sell	-432,600	Closed	-$215K	–	1252
2013 Q3	$215K	Buy	+432,600	New	+$5.06M	0.01%	703

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return

HAP Trading's EW Position: Q2 2019 in Review

HAP Trading sold out of Edwards Lifesciences (EW) in Q2 2019, closing a stake of 133,386 shares — an estimated $8.51M sold.

HAP Trading first reported a position in EW in Q3 2013 and held it in 4 quarters. The position peaked at $8.51M in Q1 2019. 921 funds tracked by Wall St. Rank hold EW as of Q2 2019.

HAP Trading reported no remaining Edwards Lifesciences position as of Q2 2019 after selling out during the quarter.
HAP Trading sold 133,386 Edwards Lifesciences shares in Q2 2019, an estimated $8.51M.
HAP Trading first reported a position in Edwards Lifesciences in Q3 2013 and held it in 4 quarters.
HAP Trading's Edwards Lifesciences position peaked at $8.51M in Q1 2019.
921 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2019.

Based on HAP Trading's 13F filing for Q2 2019, filed 14 Aug 2019.